sj-docx-1-tam-10.1177_17588359231225046 – Supplemental material for Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

Ozawa, Yuichi; Koh, Yasuhiro; Hase, Tetsunari; Chibana, Kenji; Kaira, Kyoichi; Okishio, Kyoichi; Ichihara, Eiki; Murakami, Shuji; Shimokawa, Mototsugu; Yamamoto, Nobuyuki

doi:10.25384/SAGE.25097209.v1

sj-docx-1-tam-10.1177_17588359231225046.docx (34.81 kB)

sj-docx-1-tam-10.1177_17588359231225046 – Supplemental material for Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L)

journal contribution

posted on 2024-01-28, 01:12 authored by Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa, Nobuyuki Yamamoto

Supplemental material, sj-docx-1-tam-10.1177_17588359231225046 for Prospective observational study to explore genes and proteins predicting efficacy and safety of brigatinib for ALK-gene rearranged non-small-cell lung cancer: study protocol for ABRAID study (WJOG11919L) by Yuichi Ozawa, Yasuhiro Koh, Tetsunari Hase, Kenji Chibana, Kyoichi Kaira, Kyoichi Okishio, Eiki Ichihara, Shuji Murakami, Mototsugu Shimokawa and Nobuyuki Yamamoto in Therapeutic Advances in Medical Oncology